April 22nd 2015EP. 1: Introduction: Patient-Centered Care in Oncology
April 22nd 2015EP. 2: Key Measures to Improve Oncology Care and Outcomes
April 22nd 2015EP. 3: Linking Care Outcomes With Reimbursement
April 22nd 2015EP. 4: Incorporating Patient-Reported Outcomes in Drug Labels
April 22nd 2015EP. 5: Issues in Palliative Care
April 22nd 2015EP. 6: Integrating Palliative Care Into Oncology Practice
April 22nd 2015EP. 7: Hospice: Trends, Challenges, and Solutions
April 22nd 2015EP. 8: Integrating Palliative Care Professionals Into Practice: Will It Work?
April 22nd 2015EP. 9: Influence of the 340B Drug Pricing Program
April 22nd 2015EP. 10: 340B: Additional Burdens
April 22nd 2015EP. 11: 340B: Policy Stakeholder Perspectives
April 22nd 2015EP. 12: Impact of Oral Oncolytics
April 22nd 2015EP. 13: Challenges in the Management of Oral Oncolytics
April 22nd 2015EP. 14: Practice-Based Pharmacies and Establishment of the COPA
April 22nd 2015EP. 15: Parity Laws and the Need for Payment Reform
April 22nd 2015EP. 16: The Evolution of Buy-and-Bill
April 22nd 2015EP. 17: Additional Reimbursement Considerations in Oncology
April 22nd 2015EP. 18: Factors That Influence Drug Pricing
April 22nd 2015EP. 19: Additional Pricing Considerations
April 22nd 2015EP. 20: Government Intervention in Drug Pricing
April 22nd 2015EP. 21: Drug Spend, Pricing, and Development
April 22nd 2015EP. 22: Analysis of the Oncology Care Model
April 22nd 2015EP. 23: The Oncology Care Model: Additional Concerns
April 22nd 2015EP. 24: Concerns Surrounding Enrollment into the Oncology Care Model
April 22nd 2015EP. 25: Closing Remarks and Final Considerations
